Evidence map›Paper›PMID 42317374›Full record

ArticleFrontiers in immunology2026

Impact of

Rui Liu, Zhonghua Fu, Fan Yang, Miaomiao Cao, Lixia Ma, Yuelu Guo, Biping Deng, Qinlong Zheng, Chen Chen, Bingxin Jiang and 4 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rui LiuDepartment of Lymphoma and Myeloma Research Center, Beijing GoBroad Hospital, Beijing, China.
Zhonghua FuDepartment of Lymphoma and Myeloma Research Center, Beijing GoBroad Hospital, Beijing, China.
Fan YangDepartment of Lymphoma and Myeloma Research Center, Beijing GoBroad Hospital, Beijing, China.
Miaomiao CaoDepartment of Lymphoma and Myeloma Research Center, Beijing GoBroad Hospital, Beijing, China.
Lixia MaDepartment of Lymphoma and Myeloma Research Center, Beijing GoBroad Hospital, Beijing, China.
Yuelu GuoDepartment of Lymphoma and Myeloma Research Center, Beijing GoBroad Hospital, Beijing, China.
Biping DengCytology Laboratory, Beijing GoBroad Boren Hospital, Beijing, China.
Qinlong ZhengCytology Laboratory, Beijing GoBroad Boren Hospital, Beijing, China.
Chen ChenDepartment of Biostatistics, GoBroad Research Center, Beijing, China.
Bingxin JiangDepartment of Biostatistics, GoBroad Research Center, Beijing, China.
Alex H ChangEngineering Research Center of Gene Technology, Ministry of Education, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China.
Danyang LiDepartment of Lymphoma and Myeloma Research Center, Beijing GoBroad Hospital, Beijing, China.
Xiaoyan KeDepartment of Lymphoma and Myeloma Research Center, Beijing GoBroad Hospital, Beijing, China.
Kai HuDepartment of Lymphoma and Myeloma Research Center, Beijing GoBroad Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Patients and methods: We retrospectively analyzed 195 adult patients with r/r LBCL who underwent Next-Generation Sequencing (NGS). Results: Among Conclusion: Although

Indexed as

Immunotherapy, AdoptiveLymphoma, Large B-Cell, DiffuseMutationTumor Suppressor Protein p53AdultAgedAntineoplastic Combined Chemotherapy ProtocolsFemaleHumansMaleMiddle AgedPrognosisReceptors, Chimeric AntigenRetrospective StudiesTreatment OutcomeReceptors, Chimeric AntigenTP53 protein, humanTumor Suppressor Protein p53CAR-T therapydiffuse large B-cell lymphomagenomic alterations, next-generation sequencinglarge B-cell lymphomaprognosissurvival outcomesTP53 mutations

Identifiers

PMID42317374
PMCPMC13272385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.